Serina Therapeutics enters ATM facility for up to $13.3M common stock sale

Serina Therapeutics, Inc.

Entered Capital on Demand Sales Agreement with JonesTrading for at-the-market offering of up to $13,270,500 in common stock.
JonesTrading will receive 3.0% commission on gross sales; company also reimburses up to $50,000 in legal expenses.
Sales will occur on NYSE American or other trading markets at the company's direction; no minimum obligation to sell.
Updated description of capital stock filed as Exhibit 4.1 to reflect recent certificate of designations.
Proceeds intended for general corporate purposes; offering registered on Form S-3 (File No. 333-286340).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.